Terms: = Head and neck cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Prognosis
10208 results:
1. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study.
Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ
Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277
[TBL] [Abstract] [Full Text] [Related]
2. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
Liu L; Liu Q
Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
[TBL] [Abstract] [Full Text] [Related]
4. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
[TBL] [Abstract] [Full Text] [Related]
5. Association between prognosis and lymph node status using
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
World J Surg; 2024 Mar; 48(3):650-661. PubMed ID: 38686781
[TBL] [Abstract] [Full Text] [Related]
6. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract] [Full Text] [Related]
7. Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.
Shi F; Shang L; Zhou M; Lv C; Li Y; Luo C; Liu N; Lu J; Tang M; Luo X; Xu J; Fan J; Zhou J; Gao Q; Wu W; Jia W; Wang H; Cao Y
J Med Virol; 2024 May; 96(5):e29634. PubMed ID: 38682578
[TBL] [Abstract] [Full Text] [Related]
8. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with head and neck Cutaneous Squamous Cell Carcinoma.
Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
[TBL] [Abstract] [Full Text] [Related]
9. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract] [Full Text] [Related]
10. CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair.
Qu H; Wang Y; Yan Q; Fan C; Zhang X; Wang D; Guo C; Chen P; Shi L; Liao Q; Zhou M; Wang F; Zeng Z; Xiang B; Xiong W
J Exp Clin Cancer Res; 2024 Apr; 43(1):122. PubMed ID: 38654320
[TBL] [Abstract] [Full Text] [Related]
11. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
Shen J; Ma Z; Yang J; Qu T; Xia Y; Xu Y; Zhou M; Liu W
BMC Cancer; 2024 Apr; 24(1):511. PubMed ID: 38654205
[TBL] [Abstract] [Full Text] [Related]
12. Surgical management of advanced sinonasal cancer: a 10-year mono-institutional experience.
Sileo G; Arosio AD; Lambertoni A; Battaglia P; Bignami M; Cherubino M; Valdatta L; Antognoni P; Locatelli D; Castelnuovo P; Turri-Zanoni M
Acta Otorhinolaryngol Ital; 2024 Apr; 44(2):128-137. PubMed ID: 38651554
[TBL] [Abstract] [Full Text] [Related]
13. Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma - results from a German tertiary medical center.
Struckmeier AK; Buchbender M; Lutz R; Kesting M
Clin Oral Investig; 2024 Apr; 28(5):262. PubMed ID: 38642146
[TBL] [Abstract] [Full Text] [Related]
14. Conditional survival and annual hazard of death in older patients with esophageal cancer receiving definitive chemoradiotherapy.
Chang X; Deng W; Yu R; Wang W
BMC Geriatr; 2024 Apr; 24(1):348. PubMed ID: 38632503
[TBL] [Abstract] [Full Text] [Related]
15. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Fang Q; Yuan J; Zhang X; Dai L; Luo R; Xu C
Oral Oncol; 2024 May; 152():106810. PubMed ID: 38631065
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
Chen Y; Huang Y; Chen X; Chen Z; Peng X; Lin S; Lin C; Zong J
BMC Cancer; 2024 Apr; 24(1):483. PubMed ID: 38627711
[TBL] [Abstract] [Full Text] [Related]
17. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
18. Establishment and validation of a tumor-infiltrating γδT cell related prognostic gene signature in head and neck squamous cell carcinoma.
Lu Y; Xiang Z; Wang W; Yun B; Yi C; Zhang M; Xie N; Wang C; Zhuang Z
Int Immunopharmacol; 2024 May; 132():112054. PubMed ID: 38608477
[TBL] [Abstract] [Full Text] [Related]
19. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
20. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
[Next]
